Cite
MLA Citation
P. Zinzani et al.. “PHASE 1B STUDY OF PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA (RRPMBCL): UPDATED RESULTS FROM THE KEYNOTE‐013 TRIAL.” Hematological oncology, vol. 35, n.d., pp. 189–190. http://access.bl.uk/ark:/81055/vdc_100047521632.0x000032